课题基金 / 基金详情

Integrating Competing Risks into the CISNET DFCI Breast Cancer Model

Integrating Competing Risks into the CISNET DFCI Breast Cancer Model
将竞争风险整合到 CISNET DFCI 乳腺癌模型中
批准号:
8753097
负责人:
ELLEN P MCCARTHY
金额:
$24.5万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2016-08-31

项目摘要

项目成果

ELLEN P MCCARTHY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):老年妇女乳腺癌的最佳筛查和治疗策略是不确定的,特别是对那些e75岁的人。筛查乳房X光检查的早期发现降低了50-69岁甚至74岁以下女性的乳腺癌死亡率,但筛查对e75岁的女性的好处尚不确定。美国预防服务工作组(USPSTF)得出结论,没有足够的证据建议或不建议对e75岁的女性进行乳腺癌筛查。尽管一些e75岁的妇女可能会从乳腺癌筛查中受益,但由于健康状况异常良好,许多人患有潜在的慢性病,可能无法受益,因为相互竞争的死亡风险导致的预期寿命有限。目前用于向USPSTF建议提供信息的统计模型没有充分考虑相互竞争的死亡率风险。本申请中提出的统计研究解决了与乳腺癌死亡风险竞争相关的重要方法学问题。我们将使用乳腺癌自然病史的随机模型来研究竞争风险对乳腺癌死亡率的影响。我们将把Fine和Gray的相互竞争的死亡风险直接整合到由Dana-Farber癌症研究所的Zelen和Lee开发的癌症干预和监测网络模型的方程中。CISNET-DFCI模型是用于为USPSTF乳腺癌筛查指南提供信息的7个CISNET乳腺癌模型之一,也是唯一的纯分析模型。然后,我们将通过比较新的(FG-CISNET-DFCI)模型得出的死亡率估计与原始模型和使用较不稳健的寿命表方法的模型来考虑竞争风险,来检验竞争死亡风险对特定年龄的乳腺癌死亡率的影响。然后,我们将使用FG-CISNET-DFCI模型来探索在不同情况下(例如,停止年龄、筛查间隔)乳腺癌筛查的好处和坏处。这些分析将通过提供关于不同年龄和临床(共病)特征的人群的死亡率、益处和过度诊断的数据,深入了解正在进行的关于老年妇女乳腺癌筛查的辩论。新模型还将提供将竞争风险纳入其他《信息和通信技术网络》模型的方法原型。我们的项目不仅将有助于为特定老年群体的乳腺癌筛查提供建议,还将作为解决癌症筛查是否适合老年人口的其他预防保健措施的典范。
英文摘要
DESCRIPTION (provided by applicant): Optimal screening and treatment strategies for breast cancer in older women are uncertain, particularly for those aged e75. Early detection with screening mammography reduces breast cancer mortality in women aged 50-69 and possibly up to age 74, but the benefits of screening are uncertain for women aged e75. The United States Preventive Service Task Force (USPSTF) has concluded there is insufficient evidence to recommend for or against breast cancer screening in women aged e75. Although some women aged e75 may benefit from breast cancer screening, due to exceptionally good health, many have underlying chronic illnesses and may not benefit, due to limited life expectancy resulting from competing mortality risks. The current statistical models used to inform the USPSTF recommendations do not account for competing mortality risks adequately. The statistical research proposed in this application addresses important methodological issues related to competing mortality risks for breast cancer. We will investigate the impact of competing risks on breast cancer mortality using a stochastic model of the natural history of breast cancer. We will integrate Fine and Gray's competing mortality risks directly into equations of the Cancer Intervention and Surveillance Network model developed by Zelen and Lee at Dana-Farber Cancer Institute. The CISNET-DFCI model is one of 7 CISNET breast cancer models used to inform USPSTF breast cancer screening guidelines and the only purely analytic model. We will then examine the impact of competing mortality risks on age-specific breast cancer mortality by comparing mortality estimates derived from the new (FG-CISNET-DFCI) model with the original model and a model using the less robust life table method to account for competing risks. We will then use the FG-CISNET-DFCI model to explore the benefits and harms of breast cancer screening under different scenarios (e.g., stopping ages, screening intervals). These analyses will offer insight into ongoing debate about breast cancer screening in older women by providing data on the mortality benefit and over-diagnosis in populations with different age and clinical (comorbidity) profiles. The new model will also provide a methodological prototype for integrating competing risks into other CISNET models. Our project will not only help inform recommendations for breast cancer screening in specific elderly groups, but also serve as a model to address the appropriateness of cancer screening other preventive health measures in older populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Racial Differences in CAM for Common Medical Conditions
PATTERNS CARE FOR CANCER PATIENTS AT END OF LIFE
PATTERNS CARE FOR CANCER PATIENTS AT END OF LIFE
PATTERNS CARE FOR CANCER PATIENTS AT END OF LIFE
海外基金